Stay updated with breaking news from Optimizer Smart System. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Laura Miller is telling everybody about a small medical device that has made a huge difference in her life. In fact, the 57-year-old Dunlo woman’s experience has been so dramatic,
Dive Brief: CMS has proposed giving companies including Boston Scientific and Stryker an extra year of new technology add-on payments (NTAP) for their medical devices under the agency's Fiscal 2022 Inpatient Prospective Payment System rule. Typically, CMS gives add-on payments to hospitals for two to three years after the introduction of new technologies that meet certain criteria. The agency has extended the payments for 14 products beyond the typical timeframe in light of the COVID-19 pandemic. The extension covers Boston Scientific's Eluvia drug-eluting stent, Cook Medical's Hemospray, Str...